Therapy Watch Rheumatology abstracts accepted in EULAR Abstract Book

We are delighted to announce that two abstracts from the Therapy Watch EU5 Rheumatology study have been accepted for inclusion in the EULAR Abstract Book, which is a supplement of Annals of Rhematic Disease. This will be showcased at the Annual European Congress of Rheumatology in Vienna 12-15 June, 2024.

The titles of the two abstracts are:

• To what extent is there a halo effect on class prescribing across key rheumatology indications?
• Impact of PRAC announcement on JAKi prescribing among higher-risk Rheumatoid Arthritis patients

The Therapy Watch team created the abstracts based on data from the Therapy Watch Rheumatology study. This study has been running for over 10 years, and recruits 45 Rheumatologists in each EU5 market each quarter, in which, they submit patient record forms (PRFs) for Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis.

Therapy Watch is a syndicated market tracking tool that provides market researchers and marketing teams and with real-world evidence into prescribing behaviors and market dynamics. Contact us today to learn more how we can help you address your business questions.